2018 Transactional Trends: Key Issues for Cross-Border Deals; Focus on Emerging and Mid-Size Companies Blog, Greg Benning PostsInvestment Banking TeamMay 2, 2018Harvard Medical School, Investment, Transactions
What Should Be Done About the Shrinking Number of US Public Companies? Blog, Greg Benning Posts, NewsInvestment Banking TeamFebruary 6, 2018Finance, Greg Benning, JP Morgan, JPM, Public companies
Back Bay Biopharma Confidence Index Blog, Chris Leo Posts, Greg Benning Posts, NewsInvestment Banking TeamJune 6, 2017
Acquiror or Acquiree? The Role of M&A "Deal Heat" in Premium Valuations Blog, Greg Benning Posts, Jonathan Gertler Posts, NewsInvestment Banking TeamMarch 1, 2017
Blog: Volatility Impacts Frequency of Option-Related Deals Blog, Greg Benning Posts, NewsInvestment Banking TeamMay 2, 2016Transactions, Biotech Deals
JP Morgan Healthcare Conference 2015 Recap, 2016 Outlook Blog, Greg Benning Posts, NewsBack Bay Life Science AdvisorsJanuary 31, 2016Life Science Financing, Investing
